SiriusPoint (SPNT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Net income for Q1 2026 reached $102.3 million, up from $62.0 million in Q1 2025, with operating EPS of $0.70 and a core combined ratio of 88.9%, the lowest in six quarters.
Insurance & Services gross written premium grew 8%, while Reinsurance premiums declined 10% due to disciplined risk selection and market participation.
Book value per diluted common share (ex. AOCI) increased 5% to $18.98; book value per common share rose to $19.86.
Financial strength ratings were upgraded to 'A' by S&P, Fitch, and AM Best in the last three months.
$242 million in capital was returned to shareholders, including $42 million in share repurchases and $200 million in preference share redemptions.
Financial highlights
Gross written premium was $1.0 billion, up 1% year-over-year; net earned premium increased 2% to $638.9 million.
Underwriting income rose to $77.7 million from $54.1 million, with a core combined ratio of 88.9%.
Operating net income was $86 million ($0.70 per diluted share), up 37% year-over-year.
Net investment income totaled $66.4 million; total investment result was $78 million.
Favorable prior year loss reserve development was $32.2 million, mainly from Credit and A&H lines.
Outlook and guidance
Full-year gross written premium growth expected between 5%-10%, with growth weighted to the second half and led by Insurance & Services.
Underwriting expense ratio guidance reaffirmed at 6.5%-7% for the year.
Management targets operating ROE at the top end of its 12%-15% cycle range and expects continued growth in Insurance & Services.
Positive growth prospects with a strong MGA pipeline and capital agility for reinsurance opportunities.
Continued focus on underwriting discipline, portfolio diversification, and capital allocation to profitable opportunities.
Latest events from SiriusPoint
- Q2 2026 net income rose to $69M, with 13.8% ROE and 15% Insurance & Services premium growth.SPNT
Q2 202630 Jul 2026 - Q2 and HY 2026 results show strong ROE, disciplined growth, and robust capital position.SPNT
Investor presentation29 Jul 2026 - FY25 net income up 141%, 16% premium growth, and 16.2% ROE with major capital actions.SPNT
Q4 20258 Jul 2026 - Q1 2025 saw strong premium growth, stable earnings, and upgraded ratings despite catastrophe losses.SPNT
Q1 20258 Jul 2026 - 2026 AGM features director elections, say-on-pay, auditor reappointment, and new share plan.SPNT
Proxy filing10 Apr 2026 - Q2 net income $109.9M, book value up 7.2%, and share buyback authorization at $306.3M.SPNT
Q2 20242 Feb 2026 - Q3 2024 saw improved underwriting, strong investment income, and robust capital strength.SPNT
Q3 202417 Jan 2026 - Ninth straight underwriting profit, 14.6% ROE, and 9.8% book value growth in FY24.SPNT
Q4 20249 Dec 2025 - 2025 AGM features director elections, say-on-pay, auditor approval, and highlights strong 2024 results.SPNT
Proxy Filing2 Dec 2025